High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Nakanjako, Damalie ^a   Ssewanyana, Isaac ^b   Mayanja Kizza, Harriet ^a   Kiragga, Agnes ^a   Colebunders, Robert ^d,e   Manabe, Yukari C ^a   Nabatanzi, Rose ^b   Kamya, Moses R ^a   Cao, Huyen ^c  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^c California Department of Public Health   (United States)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EFAVIRENZ; HLA DR ANTIGEN; LAMIVUDINE; NEVIRAPINE; PROGRAMMED DEATH 1 RECEPTOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE EXHAUSTION; BLOOD; COHORT ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METHODOLOGY; PROSPECTIVE STUDY; T LYMPHOCYTE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; T-LYMPHOCYTES; VIRAL LOAD;

EID: 79551688798     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-43     Document Type: Article

References (37)

1. Benito JM, Lopez M, Martin JC, Lozano S, Martinez P, Gonzalez-Lahoz J, Soriano V. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses 2002, 18(18):1379-1388. 10.1089/088922202320935456, 12487809.
2. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008, 197(1):126-133. 10.1086/524143, 18171295.
3. Massanella M, Negredo E, Perez-Alvarez N, Puig J, Ruiz-Hernandez R, Bofill M, Clotet B, Blanco J. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS 2010, 24(7):959-968. 10.1097/QAD.0b013e328337b957, 20177358.
4. Almeida CA, Price P, French MA. Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2002, 18(18):1351-1355. 10.1089/088922202320935429, 12487806.
5. Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 2009, 48(6):787-794. 10.1086/597093, 2720023, 19193107.
6. Nakanjako D, Kiragga A, Ibrahim F, Castelnuovo B, Kamya MR, Easterbrook PJ. Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS Res Ther 2008, 5:23. 10.1186/1742-6405-5-23, 2605744, 18957083.
7. Negredo E, Massanella M, Puig J, Perez-Alvarez N, Gallego-Escuredo JM, Villarroya J, Villarroya F, Molto J, Santos JR, Clotet B, et al. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clin Infect Dis 2010, 50(9):1300-1308. 10.1086/651689, 20367229.
8. Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA. CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res Hum Retroviruses 2004, 20(3):263-269. 10.1089/088922204322996482, 15117448.
9. Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation. J Infect Dis 2005, 192(12):2142-2146. 10.1086/498168, 16288380.
10. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003, 187(10):1534-1543. 10.1086/374786, 12721933.
11. Baker CA, Emenyonu N, Ssewanyana I, Jones NG, Elrefaei M, Nghania F, Nakiwala J, Andia I, Clark R, Martin J, et al. Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy. AIDS Res Hum Retroviruses 2007, 23(7):900-905. 10.1089/aid.2006.0309, 17678474.
12. Cassol E, Malfeld S, Mahasha P, van der Merwe S, Cassol S, Seebregts C, Alfano M, Poli G, Rossouw T. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J Infect Dis 2010, 202(5):723-733. 10.1086/655229, 20629534.
13. Borkow G, Weisman Z, Leng Q, Stein M, Kalinkovich A, Wolday D, Bentwich Z. Helminths, human immunodeficiency virus and tuberculosis. Scand J Infect Dis 2001, 33(8):568-571. 10.1080/00365540110026656, 11525348.
14. Rosignoli G, Lim CH, Bower M, Gotch F, Imami N. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol 2009, 157(1):90-97. 10.1111/j.1365-2249.2009.03960.x, 2710596, 19659774.
15. Rosignoli G, Cranage A, Burton C, Nelson M, Steel A, Gazzard B, Gotch F, Imami N. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. AIDS 2007, 21(10):1379-1381. 10.1097/QAD.0b013e3281de7296, 17545722.
16. Venkatachari NJ, Buchanan WG, Ayyavoo V. Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo. Virology 2008, 376(1):140-153. 10.1016/j.virol.2008.03.015, 18440040.
17. Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, et al. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007, 46(2):187-193. 10.1097/QAI.0b013e31814278c0, 17693883.
18. Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek DC, Mbisa G, Deeks S, et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001, 15(14):1749-1756. 10.1097/00002030-200109280-00002, 11579235.
19. Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis 2005, 41(3):361-372. 10.1086/431484, 16007534.
20. Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, Aiuti F. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy. Clin Exp Immunol 1999, 118(1):87-94. 10.1046/j.1365-2249.1999.01033.x, 1905399, 10540164.
21. Bouscarat F, Levacher M, Landman R, Muffat-Joly M, Girard PM, Saimot AG, Brun-Vezinet F, Sinet M. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 1998, 12(11):1267-1273. 10.1097/00002030-199811000-00007, 9708405.
22. Valdez H. Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). AIDS Rev 2002, 4(3):157-164.
23. De Maria A. Discordant responses to HAART in HIV-1 patients: the need to focus on intervention. Expert Rev Anti Infect Ther 2007, 5(4):523-527. 10.1586/14787210.5.4.523, 17678414.
24. Watson C, Jenkinson S, Kazmierski W, Kenakin T. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol Pharmacol 2005, 67(4):1268-1282. 10.1124/mol.104.008565, 15644495.
25. Mwagomba B, Zachariah R, Massaquoi M, Misindi D, Manzi M, Mandere BC, Bemelmans M, Philips M, Kamoto K, Schouten EJ, et al. Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One 2010, 5(5):e10452. 10.1371/journal.pone.0010452, 2864258, 20454611.
26. Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, et al. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis 2008, 197(9):1324-1332. 10.1086/587184, 2423492, 18422445.
27. Lawn SD, Little F, Bekker LG, Kaplan R, Campbel E, Orrell C, Wood R. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. Aids 2009, 23(3):335-342. 10.1097/QAD.0b013e328321823f, 19114870.
28. Bandera A, Ferrario G, Saresella M, Marventano I, Soria A, Zanini F, Sabbatini F, Airoldi M, Marchetti G, Franzetti F, et al. CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS One 2010, 5(5):e10788. 10.1371/journal.pone.0010788, 2875388, 20520721.
29. Gazzola L, Tincati C, Bellistri GM, Monforte A, Marchetti G. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. Clin Infect Dis 2009, 48(3):328-337. 10.1086/595851, 19123868.
30. Sondora LD, Silvestri G. Immune activation and AIDS pathogenesis. 2008, http://www.medscape.com/viewarticle/575812
31. Lule JR, Mermin J, Ekwaru JP, Malamba S, Downing R, Ransom R, Nakanjako D, Wafula W, Hughes P, Bunnell R, et al. Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg 2005, 73(5):926-933.
32. Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006, 367(9518):1256-1261. 10.1016/S0140-6736(06)68541-3, 16631881.
33. Mermin J, Lule JR, Ekwaru JP. Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 2006, 41(1):129-130. 10.1097/01.qai.0000179427.11789.a7, 16340488.
34. Watera C, Todd J, Muwonge R, Whitworth J, Nakiyingi-Miiro J, Brink A, Miiro G, Antvelink L, Kamali A, French N, et al. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr 2006, 42(3):373-378.
35. D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, Wilson CC, Connick E, Palmer BE. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 2007, 179(3):1979-1987.
36. Piconi S, Trabattoni D, Gori A, Parisotto S, Magni C, Meraviglia P, Bandera A, Capetti A, Rizzardini G, Clerici M. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS 2010, 24(13):1991-2000. 10.1097/QAD.0b013e32833c93ce, 20651586.
37. Ssewanyana I, Baker CA, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. AIDS Res Hum Retroviruses 2009, 25(1):65-71. 10.1089/aid.2008.0138, 2858297, 19182922.